Preston teen's medical cannabis at risk after firm's collapse

2
Skip to next photo
1/1
Show caption
1/1
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The Herald.

A Preston teen who relies on medical cannabis to treat as many as 150 seizures a day faces supplies running out after the firm that makes the £ 2,000-a-month drug went bust.

Ben Griffifths, 17, was diagnosed with cerebral palsy and severe epilepsy at birth.

For years, no medication worked, and Ben experienced around 100 seizures a day.

The impact of the seizures threatened his heart, and Ben has previously been in critical condition because of them.

His parents, Joanne, 51, and Paul Griffifths, 47, did their own research and eventually found a cannabis oil from a medical cannabis producer, Bedrocan, that dramatically improved Ben's condition.

They were unable to get it through the NHS but can get it prescribed privately and imported from the Netherlands, which has cost them £192,000 over eight years.

The oil reduces Ben's seizures to just six a day.

But in October, Bedrocan was declared bankrupt, and the parents have been warned they only have a month of the medication left.

Now, Joanne and Paul are desperate to raise awareness and find a way to save their son. If nothing changes, they fear his seizures will become too extreme for Ben to survive.

Joanne, director and campaign manager for the campaign group End Our Pain, and co-founder of the charity Interactable Epilepsy, said: "We've had to pay nearly £2,000 a month for eight years for this medication, because it's the only thing that works.

"There's less than five patients that get access to unlicensed cannabis oil through the NHS, and that's it. We didn't have a choice.

"We have a UK prescription, too, but they can't access the flower to manufacture the oil.

"But the pharmacy in Holland is closing on December 1 and won't be making the specific oil my son needs.

"It's life or death now."

Paul, a surveyor, said: "We're both desperate.

"Without the medication, we don't know what will happen. When we ran out before through a prescription error, he nearly died in hospital.

"His oxygen levels dropped to 72 per cent, and his heart rate was at 218 beats per minute."

Initially, nothing seemed to help Ben's condition after his diagnosis.

Joanne said: "He's basically suffered 100 seizures plus a day for most of his life. In 2014, he was on four different epilepsy drugs at the time, but we were told none of them were working.

"He was having over 90 seizures in 24 hours, so they said we needed to remove the ineffective drugs and consider his quality of life.

"We asked about medical cannabis at that time, but it was only being trialled on two rare conditions.

"Then finally, in 2018, we were given opportunity to trial medical cannabis oil from Canada. He went from 100 seizures a day to six.

"We trialled it but weren't able to get it through the government access panel, so when it ran out, my son started having hundreds of seizures again.

"The NHS gave him Epidiolex instead through a compassionate access scheme, but he had an awful reaction. He had 194 seizures in 18 hours and shortly afterwards became completely unresponsive.

"He couldn't urinate, walk, eat or drink. It was a combination of the side effects of the medicines and the fact he was having so many seizures. His health was just deteriorating."

Despite knowing that the specific cannabis oil would help Ben, NHS doctors were unable to prescribe it because it isn't licensed yet in the UK - despite already providing it for five children in the country.

But Paul and Joanne were able to get a prescription for an unlicensed cannabis oil made and dispensed in the Netherlands through a private doctor.

Joanne said: "It costs us £2,000 a month, but it gave him quality of life.

"But now we've been told the pharmacy is closing, and it's the only one that produces the oil he can take."

For 23 years, Bedrocan supplied standardised medicinal cannabis under contract to the Dutch Government.

That contract ended on January 1, yet the legislation allowing the company to trade independently has been delayed until 2028.

Bedrocan’s Dutch companies have now been declared bankrupt.

Joanne said: "We've been campaigning for over 10 years for more studies to take place in the UK, so this medication can be licensed for children.

"For the past eight years we've been told by the government that they need more evidence before they can roll out access to medical cannabis for children. But they refuse to do any observational studies.

"The government cannot keep saying we need more evidence when they're actually failing to collect that evidence.

"We need Andy Burnham to immediately intervene because access to our children's medicine is being threatened."

Ben has five siblings: four sisters and a twin brother, Adam.

Joanne said: "His twin is distraught; he reached out personally to Andy Burnham, but he is yet to respond to him.

"We're not coping very well, to be honest. It's horrific.

"We've written directly to the Prime Minister, and for two years we've been asking for a meeting. We've had nothing from our own government, but I had a response from the Dutch government within a week.

"Ben has a life now. Why should he have to return to having no quality of life due to government inaction?"

The Medical Cannabis Clinicians Society (MCCS) is calling for urgent action to protect UK patients who rely on Bedrolite following the insolvency of the cannabis producer Bedrocan.

The MCCS has written urgently to the Secretary of State for Health and Social Care, the Rt Hon Yvette Cooper MP, asking the UK Government to intervene.

The issue was raised in the House of Commons on October 15, but so far, no action has been taken.

Get involved
with the news

Send your news & photos